Clinical Study of Lamotrigine to Treat Newly Diagnosed Typical Absence Seizure in Children and Adolescents

Trial Identifier: 115377
Sponsor: GlaxoSmithKline
NCTID:: NCT01431976
Start Date: September 2011
Primary Completion Date: February 2014
Condition: Epilepsy

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Version

Trial Locations

Country Location
Japan Aichi, Japan, 453-8511
Japan Ehime, Japan, 790-8524
Japan Fukuoka, Japan, 814-0180
Japan Hiroshima, Japan, 730-8518
Japan Hokkaido, Japan, 006-0041
Japan Kanagawa, Japan, 232-8555
Japan Niigata, Japan, 950-2085
Japan Okayama, Japan, 700-8558
Japan Shizuoka, Japan, 430-8558
South Korea Seoul, South Korea, 120-752